Stockreport

Bavarian Nordic in pact with global vaccine group, Gavi for 500K mpox vaccines Sep. 18, 2024 8:14 AM ET By: Dulan Lokuwithana , SA News Editor [Seeking Alpha]

BAVARIAN NORDIC R/I S/ADR  (BVNRY) 
NASDAQ:AMEX Investor Relations: bavarian-nordic.com/investor.aspx
PDF ) to procure 500,000 doses of the Danish biotech's FDA-approved MVA-BN mpox vaccine. The deliveries expected in 2024 will be dispatched to African countries affected [Read more]